FDA Hearing On ‘Hemp-Derived CBD’ Today
Washington, DC: Today the US Food and Drug Administration is taking in-person public testimony with regard to the “manufacturing, product quality, marketing, labeling, and sale” of CBD-infused retail products.
“The rapidly evolving hemp-derived CBD marketplace sadly includes a number … Read the article
This post appeared first on https://blog.norml.org/?p=16150.